January Nicotinamide prices moved higher on firmer import costs driven by early-year buying and tighter Asia-origin offers. Importers and formulators accelerated purchases to secure cargoes ahead of the spring wellness season, while loading offers from China and premium European suppliers supported a pricing floor. Traders redirecting volumes to price-sensitive Southeast Asian markets tightened US spot availability through mid-month, leaving inventories lean and prompting buyers to accept higher quotations to meet front-loaded blending schedules. Demand from dietary supplements and cosmeceuticals was the principal driver of the uplift. The nutraceutical channel accelerated premix purchases and blending ahead of the seasonal rush, while cosmeceuticals demand for anti-aging applications contributed to the uptick, alongside a modest global demand rise. By contrast, pharmaceuticals and beverage/pet-nutrition users remained more measured. Prices rose about eight percent month-on-month, reflecting tight Asia-origin offers and premium supplier positioning. Outlook points to modest further gains ahead, with softening and partial recovery expected later in the year, contingent on replenishment dynamics.
The import market of the Nicotinamide in the US has observed a significant increase in the first month of year ****. The market value of Nicotinamide in the US import market has moved higher in January **** as the early-year buying and tighter Asia-origin offers set a firmer import cost floor. The early January saw importers and formulators have accelerated their purchases to secure cargoes ahead of the March wellness and spring retail season and mid-month pricing was lifted further when China and premium European Nicotinamide suppliers pushed up loading offers. Traders redirecting volumes to price-sensitive Southeast Asian markets narrowed US spot availability through the mid-to-late month, leaving inventories lean and prompting buyers to accept higher quotations to meet front-loaded blending schedules and premix commitments.
The Nicotinamide demand from dietary supplements and cosmeceuticals was the principal driver of the January uplift. The dietary supplements/nutraceuticals...
About ChemAnalyst
Leave a Comment
Comments (0)